New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 7, 2014
06:41 EDTAKERAkers Biosciences signs distribution agreement for infectious disease tests
Akers Biosciences announces a distribution agreement with Thirty Six Strategies General Trading, for the sale of the Company's PIFA PLUSS Infectious Disease Rapid Assay product line and Tri-Cholesterol "Check". The three year exclusive agreement is subject to performance minimum purchase requirements. 36S is permitted to market the Company's products in Australia, Singapore, the United Arab Emirates and Oman. Under the terms of the distribution agreement 36S is expected to immediately begin marketing the company's tests to a large and varied customer base including hospitals, paramedic and emergency services, non-governmental organizations and military forces. 36S will focus on distribution of the company's rapid HIV, Hepatitis B, Malaria and Dengue Fever tests; as well as its rapid cholesterol test, Tri-Cholesterol "Check".
News For AKER From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 14, 2015
07:17 EDTAKERAkers Biosciences reports Q1 revenue $510K, may not compare to one estimate $2M
May 12, 2015
07:32 EDTAKERAkers Biosciences introduces two new breath tests
Akers Biosciences introduced two new breath tests to the U.S. market from the company's Akers Wellness division at the World Congress on Anti-Aging Medicine in Hollywood, Florida, last week. BreathScan OxiChek and BreathScan KetoChek, together with the Bluetooth-enabled reading device, BreathScan Lync - which synchs via an app on any mobile device - will enable users to monitor trends in critical metabolic processes. The products will provide healthcare professionals, suppliers of nutritional supplements and weight loss plans, as well as health coaches, the ability to more effectively demonstrate, monitor and adjust the efficacy of their products and the progress of their clients. These products may also provide such customers with an opportunity for significant revenue enhancement through distribution for in-office and at-home use of the devices.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use